Clinical Trials Directory

Trials / Unknown

UnknownNCT02742207

Renal Function Post Cardioversion for Atrial Fibrillation

Evaluation of Renal Function and Fluid Balance of Patient Undergoing Electrical Cardioversion for Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation is a common arrhythmia which requires electrical cardioversion in many patients in order to regain sinus rhythm. In a previous retrospective study a complication of acute renal failure was found in 17% of the patients after cardioversion.(The incidence and prognosis of renal dysfunction following cardioversion of atrial fibrillation. Helman Y,...Gilon D et al:Cardiology 2013;124(3);184-9.) Another complication previously described after cardioversion is pulmonary edema. In this prospective study the investigators aim to evaluate the risk of acute renal failure post cardioversion. In addition the investigators would like to evaluate hemodynamic changes, fluid balance and sodium levels in patients post cardioversion as a potential mechanism for both acute renal failure and pulmonary edema post cardioversion. In order to assess hemodynamic changes the investigators will use a non-invasive FDA approved device called NICaS (Non-Invasive Cardiac System). This system calculates cardiac output, cardiac index and peripheral vascular resistance in a non-invasive, fast and accurate way.

Conditions

Interventions

TypeNameDescription
OTHERElectrical atrial fibrillation CardioversionElectrical cardioversion for patients admitted for Atrial Fibrillation
OTHERCardioversionElectrical cardioversion for patients admitted for Atrial Fibrillation

Timeline

Start date
2018-07-11
Primary completion
2020-07-01
Completion
2020-12-01
First posted
2016-04-18
Last updated
2019-08-07

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02742207. Inclusion in this directory is not an endorsement.